• Odyssey Group International Inc. is a Nevada based medical company developing a variety of drug and technology assets to treat unmet clinical needs
• Odyssey CEO Michael Redmond recently appeared on Bloomberg TV’s The RedChip Money Report(R) to discuss the development pipeline for three of the company’s four products and pending clinical testing
• Odyssey’s assets include treatments for patients who may have undiagnosed heart disease, patients choking on some type of obstruction lodged in their throats, patients dealing with a rare neurodegenerative disorder and patients needing treatment for brain concussion injuries
• The drug-device combination for treating concussions is advancing in a Phase 1 clinical human trial that is currently enrolling 48 patients

Sixty-five years after retired business and senior finance executive Bob Valentine received life-saving care in Children’s Hospital of Buffalo’s neonatal intensive care unit (“NICU”) to treat respiratory distress syndrome he experienced as a newborn, Valentine made a Valentine’s Day donation of $500,000 this year to the hospital’s foundation, which established a fund to help families experiencing a similar journey (https://ibn.fm/VbhyF). Valentine’s expression of gratitude for what was then revolutionary medical care is by no means unique in the annals of emergency treatments that have helped patients overcome traumatic developments and go on to pursue their lives. A Long John Silver’s business executive recently gifted $1 million to a university’s research fellowship after cardiothoracic surgery there resolved heart problems that endangered his life (https://ibn.fm/Sq4HR). And sometimes the expressions of gratitude have a more intangible value, such as when a family publicly praised a police officer’s CPR efforts that saved a choking child, who wrote the officer a thank you card (https://ibn.fm/Js38d). Odyssey Health (OTC: ODYY) is dedicated to advancing lifesaving medical products that offer similar levels of hope to a new generation of people through technological and clinical developments that demonstrate advantages over current standards of care. At the moment, Odyssey’s market profile includes two medical device candidates and two pharmaceutical products in development. The portfolio is responding to varied needs, including patients who may have undiagnosed heart disease, patients choking on some type of obstruction lodged in their throats, patients dealing with a rare neurodegenerative disorder and patients needing treatment for brain concussion injuries. CEO Michael Redmond spoke with The RedChip Money Report(R) on Bloomberg TV this month to explain the company’s business model and acknowledge the involvement of professional football athletes in the development of the concussion treatment and plans for human trials (https://ibn.fm/Liyny). There currently is no FDA-approved drug to treat concussions, according to the company, making its efforts a potentially leading-edge solution. “We will provide a clinical advantage in the marketplace,” Redmond said during the interview. “We have a very unique new chemical entity intended to treat mild traumatic brain injury — the acute phase of a concussion. It’s a small device. It essentially delivers a powderized drug through the upper chambers of the nasal cavity. The drug crosses the blood-brain barrier within five minutes. It spreads out throughout the brain within 30 minutes and reverses the effects of a concussion” (https://ibn.fm/Gpjs7). Redmond said the company’s preclinical lab animal tests indicate the drug is safe and efficacious. Lab reports have been produced and the drug had been approved to advance to a Phase 1 clinical human trial for the drug-device combination. Results from the first cohort of the trial indicate the drug was well tolerated and no adverse events were observed. The cardiological prototype device is also unique, with nothing else in the marketplace able to match its rapid ability to map the heart, Redmond said. The anti-choking device seeks to stand out above existing competitors with its portability and efficacy. The interview did not address the drug being developed to treat the rare neurodegenerative disorder Niemann-Pick disease. “They have strong IP positions — on all three of them,” Redmond said. “We believe that we have the management, the Board of Directors, and the experience level … that will allow us to successfully commercialize all three of these products and create significant value for the company.” For more information, visit the company’s website at https://odysseygi.com/. NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY

• Since the summer of 2021, the number of users with access to the Lightning Network has increased from approximately 100,000 to over 80 million
• LQwD’s current channel count on the Lightning Network is 17 and connects countries worldwide
• LQwD currently has active nodes spanning the US, Japan, England, Canada, France, Italy, Indonesia, Bahrain, South Africa, South Korea, Sweden, Singapore, Hong Kong, Brazil, Germany, India, and Ireland
• Company executive Stephen Thompson wrote an article for Bitcoin Magazine expressing that Bitcoin (as a network) could be the additional layer of trust needed with the internet infrastructure today

Over the last 30 days, the Bitcoin Lightning Network (“LN”) has experienced an increase in channel capacity, despite the current decline and bear market being experienced by much of the cryptocurrency world. The current capacity is teetering at the 4,000 BTC mark, translating into a growth of over 5% across the last 30 days (https://ibn.fm/0EKro). Arcane Research’s The State of Lightning Volume 2 was released in April 2022 and used transactional data from the platform to support its findings. With the adoption of the Lightning Network platform quickly rising, the research indicated that the number of payments over the past year has doubled, and the value of the transactions has increased by about 400%. Comparing last summer (2021) to March 2022, it was determined that the number of users with access to the Lightning Network has increased from approximately 100,000 to 80 million, respectively (https://ibn.fm/VRenr). LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a fintech company focused on creating enterprise-grade infrastructure to drive bitcoin adoption, has been scaling its capacity on the network to drive awareness and growth. The company’s flagship platform as a service (“PaaS”) offering, https://lqwd.tech/, was released in November 2021 in addition to the first company node on the Lightning Network – US-West. As the company’s longest operating node, the US-West node’s capacity is the highest – 5.73377252 BTC, which translates to 573,377,252 satoshi/ US $121,051.86. Currently, 104 channels and 103 connected nodes are active on the network to the company’s Lightning Network node. Over the last 30 days, the US-West node has experienced growth overall, an increase of .250353 BTC (+4.57%) with an average channel capacity on the node of .055 BTC (US $1,162.01). Including US-West, the current node count operated by LQwD on the Lightning Network is 17. These nodes facilitate transactions in destinations worldwide, including Japan, England, Canada, France, Italy, Indonesia, Bahrain, South Africa, South Korea, Sweden, Singapore, Hong Kong, Brazil, Germany, India, and Ireland. Using the Lightning Network instead of the blockchain for transactions brings multiple benefits to users, such as faster settlement times and lower fees. The company has invested its own bitcoin reserves in creating its pathways across the Lightning Network. To follow LQwD’s progress on the Network, visit www.1ml.com. Bitcoin Magazine recently published an opinion piece by Stephen Thompson, the senior technical editor at LQwD (https://ibn.fm/fxCdx). In the article, Stephen discusses how Bitcoin’s trustless nature adds trust to the internet. He explains the current seven-layer structure of the internet (physical, data link, network, transport, session, presentation, and application) and how Bitcoin could essentially be a new layer of added trust. The layer refers to Bitcoin the network (not bitcoin the asset) as a trust protocol that defines the rules governing the network and protecting it from attacks. In his guest post, Thompson underlines that a combination of better technology with people allowing it to play a prominent daily role will help to improve trust overall. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• Golden Matrix Group, Inc has been a major beneficiary of the growth in online gaming as well as the ongoing regulation and legalization of online casinos and online sports betting Globally
• The Company has expanded its white-label B2B offering through the launch of the GM-X and GM-Ag turnkey solution, a complete software package designed to allow land-based operators to transition into providing online operations
• GMGI have separately sought to bolster their B2C offering, most recently through the acquisition of a controlling stake in UK-based RKingsCompetitions, a leading online competition company in the UK and Northern Ireland
• In addition to contributing over $5.1 million to GMGI’s top-line revenues in the most recent quarter, RKings’ has also been responsible for providing GMGI with upwards of 45,000 new customers per quarter

In 2006, the United States passed the Unlawful Internet Gaming Enforcement Act, infamously banning all remote gambling in the US overnight. At the time, the law acted seemed like a death knell for the sector. The sector has recently experienced a rebirth following the Supreme Court’s decision in 2018 to repeal the Professional and Amateur Sports Protection Act (“PASPA”) – clearing the way for legalized sports bettering across the nation. In just four years, the industry has worked itself into the daily lives of millions of Americans and today most major countries in the world have rules regulating online gambling rather than banning the activity. The global online gambling market size is expected to reach USD 153.6 billion by 2030, registering a CAGR of 11.7% from 2022 to 2030, according to a new report by Grand View Research, Inc.** Amongst the beneficiaries was Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms and systems and a portfolio of over 10,000 third party games. Golden Matrix Group pioneered the creation of their GM-X turnkey solution, a complete software package designed to support online gaming businesses. Designed to provide platform operators with a broad array of tools – ranging from player registration and management through to payment solutions and content management, GMGI’s solution has proved to be a boon for companies wishing to focus on the marketing aspect of their businesses whilst operating a proven set-up. Benefitting from their partnership with upwards of 25 gaming content providers, GMGI have established a portfolio of over 10,000 games ranging from online slots, casino table games, live operator games, and more. Moreover, the company have been actively seeking to bolster their portfolio, recently entering a partnership with online video-slot game provider, Endorphina (https://ibn.fm/JkrVP) which saw the company amalgamate Endorphina’s portfolio of 100 games to Golden Matrix’s selection. Golden Matrix’s efforts have had a marked impact on their financial results. The company reported record revenues of $8.5 million for the three months ending April 30, 2022, an increase of 221% relative to the equivalent period a year ago. Meanwhile, net income over the course of the quarter rose by upwards of 359%, a remarkable increase representing the company’s 15^th consecutive quarter of profitability. In addition to their burgeoning B2B offering, Golden Matrix Group have also been actively working towards growing their B2C offering, an initiative which saw the company acquire an 80 percent controlling interest in UK-based RKingsCompetitions Ltd., a leading independent online competition company (https://ibn.fm/qx8wz) in November 2021. In addition to contributing approximately $5.1 million of the group’s total revenues for the quarter, RKings’s unique competitions have also resulted in GMGI acquiring forty-five thousand new players a quarter at relatively low cost – a crucial factor towards growing out their addressable consumer universe. Golden Matrix CEO, Brian Goodman, commented on the company’s growth outlook as well as the outlook for their B2B and B2C segments following their recent earnings release, “We are excited to report our second quarter as a company with both B2B and B2C verticals”. He continued, “We enter the remainder of 2022 with two robust operating divisions and a strong balance sheet. As stated previously, we continue to evaluate new opportunities in both the B2B and B2C spaces that we believe will further accelerate GMGI’s overall revenue growth and – in accordance with our acquisition strategy – are always accretive to earnings.” For more information, visit the company’s website at www.GoldenMatrix.com. NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

• Flora Growth completed the acquisition of Just Brands LLC and High Roller Private Label LLC, owners of the JustCBD brand, on February 28, 2022
• The company then expanded its operational footprint in Europe and the UK in May 2022 to further its international growth strategy
• JustCBD products, including gummies and tinctures, will be available on www.Amazon.co.uk starting this month in a pilot-only program
• Flora Growth is optimistic that this launch will allow the company to reach a larger consumer base as it works towards further expanding its operations across Europe

On February 28, 2022, Flora Growth (NASDAQ: FLGC) completed the acquisition of 100% equity interests of Just Brands LLC and High Roller Private Label LLC, owners of the JustCBD brand. The transaction, which involved a consideration of $16 million in cash and 9.5 million in privately issued Flora common shares, was a move by Flora Growth to explore global expansion opportunities and increase the company’s customer database (https://ibn.fm/UmDpP). By mid-May 2022, Flora Growth had already announced the expansion of its operational footprint in Europe and the United Kingdom to further its international growth strategy. But, more importantly, the move signaled the company’s assertive push to broaden the reach for its JustCBD’s 79 products registered with the UK Novel Foods, paving the way for meaningful distribution of its growing house of brands. “Establishing our roots in the UK and EU will not only afford us opportunities to increase our distribution and grow market share, but it will generate actionable market insights for our team to continue to innovate and deliver the most compelling experiences we can,” noted Luis Merchan, Flora Growth’s President and Chief Executive Officer (“CEO”) (https://ibn.fm/shGj3). In what marks a noteworthy milestone for Flora Growth and its expansion plan, the company announced that JustCBD would launch its Novel Foods registered CBD products on Amazon.co.uk. JustCBD’s product line will be available on the site starting this month, making available a portfolio of the company’s best-selling gummies and tinctures. “With health and wellness playing an increasingly important role in customers’ lives, we are excited to increase the selection of quality CBD products offered to Amazon customers in the UK,” noted Hussein Rakine, the CEO of JustCBD. “The JustCBD team looks forward to working closely with Amazon to expand our product offering to other countries as our partnership and brand presence in the United Kingdom Grows,” he added (https://ibn.fm/xSTBx). The CBD market in the UK is currently valued at £700 million and is projected to hit £1 billion by 2025. This growth is attributed mainly to the UK’s regulatory framework, which is regarded as the most evolved in the world. Such structures have seen key corporations such as Amazon venturing into this market, introducing a pilot-only program that includes vendors who have already demonstrated compliance with the UK CBD Novel Food regulations. JustCBD has already undergone the Novel Food regulations approval process and has been awarded the necessary authorization proving that its products are safe for consumption and labeled correctly. With the launch of its product line on Amazon UK, Flora Growth is optimistic that it will reach a larger consumer base even as it works towards further expanding its operations across Europe. “International growth is a key objective of our company’s strategy,” noted Mr. Merchan. “The launch of Amazon UK allows Flora to reach a larger consumer base in search of quality CBD products. We are excited to continue expanding our operations in Europe and to deliver top-quality cannabis-related products to customers aiming to improve their health and wellness,” he added. For more information, visit the company’s website at www.FloraGrowth.com. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

Issuers, investors, members of executive management, thought leaders, and individuals well-versed in the digital assets space are invited to attend the conference on Digital Assets: Exploring The Metaverse And Crypto Assets (“Digital Assets Conference”), being held on June 23, 2022, as a wholly online, virtual event. This event will showcase presentations and commentary from innovative emerging companies and industry leaders in key focus areas including bitcoin, NFTs, other digital assets, emerging regulations, and the metaverse. The Digital Assets Conference is a world-class event organized by M-Vest, a division of the Maxim Group LLC, a leading full-service investment bank, securities, and wealth management firm. M-Vest provides access to online investment opportunities and a digital community for issuers, investors, and thought leaders to share information, discuss capital raisings and garner market insights on current market trends. The event will host virtual panel discussions with leading executive management2222 teams from public and private companies, moderated by seasoned research analysts at Maxim Group. The Digital Assets Conference also facilitates engagement with a lively and dynamic investor community and provides participating attendees access to live events and insightful Q & A sessions. As a result, emerging companies will have the opportunity to connect with veteran investors, achieve recognition and broaden their networks. At the Digital Assets Conference, session themes include Exchanges, Mining, Gaming/Metaverse, NFT – Platforms, and NFT – Creative. Panel discussions will tackle a wide variety of industry aspects including the impact of rising rates on the value of bitcoin; NFTs, and other digital assets; future market opportunities; and development around collectibles and gaming; emerging regulation around crypto-assets and trading; as well as the application of NFTs and the metaverse to personal identity. Panelists will include industry experts from prominent private companies such as Crosstower, Pink Panda, Qenta Inc., Poolin, NFTSTAR, and Loot NFT Co. Marquee public companies in attendance are Digihost Technology, LM Funding America, Sphere3D and many more across a wide gamut of sectors. Hurry and reserve your seat at MVest events!

• Global efforts to address climate change are expected to drive an economic market that Special Presidential Envoy for Climate John Kerry argues will ultimately be larger than the Industrial Revolution was
• While energy efficient commercial buildings have rapidly increased in the United States and Canada during recent years, the mission of sustainability must be spread among construction and development professionals.
• Green energy solutions company Correlate Infrastructure Partners Inc. is helping companies reduce their carbon footprint through it’s data-centric platform for analyzing corporate facilities’ energy usage and spearheading their sustainability solutions
• Correlate’s services make it possible for companies to be apart of the solution by achieving greater energy efficiency and access to locally sited solar, energy storage and EV infrastructure

While climate change worries have been expressed as a threat to future life, Special Presidential Envoy for Climate John Kerry recently cast a more optimistic vision of the potential that climate change represents in terms of economic possibilities. “This is the largest market the world has ever been staring at: the energy transition market,” Kerry told attendees at the IV CEO Summit of the Americas in Los Angeles on June 9 (https://ibn.fm/4IbtG). “Every aspect of life can be impacted in a positive way. It’s not something to fear — that we have to shun and shy away from. We have to embrace this transition which will, in the end, I guarantee you, be larger than ultimately than the Industrial Revolution was.” Louisiana-based Correlate Infrastructure Partners (OTCQB: CIPI) is a purpose-built energy use optimization company pursuing green utilities solutions for the commercial real estate industry. They are innovating the industry with the mission of sustainability, and the kickback of increased net operating income. The company is one of many whose enthusiasm mirrors Kerry’s faith in the idea that finding solutions for reducing carbon emissions is sound business sense. “Correlate Infrastructure Partners is making energy management and procurement transparent and cost-effective as we digitize the process that has been archaic for way too long. We are excited to be at the forefront of an industry that is at an inflection point, and we are eager to begin working to change the way commercial real estate owners optimize energy assets,” CEO Todd Michaels stated last month. The company uses proprietary data analysis and concierge services to help facilities owners and construction professionals evaluate and improve their energy usage footprints, providing the necessary information to work through what Utah’s Clean Energy authorities branded a “net-zero learning curve” (https://ibn.fm/0yApb). Media outlet CleanTechnica recently reported on data published by the journal iScience, showing that “the people operating renewables like solar and wind farms are learning to do so more efficiently, lowering the levelized cost of electricity (‘LCOE’)” and financing rates for related assets (https://ibn.fm/FF6ug). According to the researchers, LCOE refer ?s to cost metrics spread across the lifetime of an operation, and in regard to the wind energy market the average cost per megawatt-hour (“MWh”) fell from $440 when the market launched in 1982 to $32 in 2020 — a reduction of 93 percent. The LCOE for utility scale solar energy fell from $230 per MWh when it began in 2007 to $34 per MWh in 2020 — a rapid 85 percent decline. The news is encouraging to those striving to reduce carbon dioxide emissions. The Statistics Division of the United Nations has reported that for the terms outlined in the Paris Accords seven years ago to be accomplished, global CO2 emissions must be cut to 55 percent of their 2010 levels by 2030 and reach net-zero by 2050 (https://ibn.fm/wNUco). For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• Eat Well Investment Group has focused on expanding its product offerings, targeting both small and large businesses, and has successfully grown its retail footprint with the addition of notable retailers in both the U.S. and Canada
• Its aggressive expansion has seen Eat Well serve customers in over 35 countries, with projected revenue of $100 million in 2022
• The company is confident that, with current opportunities in the plant-based sector, it will achieve its 2022 revenue target and create value for its shareholders

At the close of the 2021 calendar year, Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) announced the appointment of Marc Aneed as its new Chief Executive Officer (“CEO”). Mr. Aneed, having taken over from retiring David Doherty, assured investors that the company would also remain focused on driving shareholder value into 2022 and beyond (https://ibn.fm/bbreb). Under his leadership, Eat Well Investment Group has disrupted the multi-billion snack food market. In addition, it has fortified its vertically integrated approach to feeding people delicious, more nutritious food, at a lower cost. The company also completed strategic acquisitions, most notably, Sapientia. In addition, Eat Well closed a strategic investment from Nurture Health Food LLP. Mr. Aneed notes that this investment will be integral to the company’s international growth while setting the stage for further collaboration (https://ibn.fm/4U687). Eat Well’s aggressive expansion under Mr. Aneed’s leadership would also see the company announce that its majority-owned portfolio company, Amara Organic Foods, would be available in approximately 200 HEB Grocery Company, LP locations across the U.S. within the first quarter of the 2022 fiscal year. The additional distribution added to Amara’s strong retail footprint, which comprised Walmart Canada, Whole Foods, Costco, Sprouts Farmer’s Market, Sobeys, and Loblaws. In June, Eat Well announced the addition of another distributor to its roster – The Kroger Co. While making the announcement, Eat Well noted that Amara Organic Foods would now be available on The Kroger Co.’s eCommerce platforms, a welcome addition to Amara’s omnichannel sales distribution strategy (https://ibn.fm/55cfm). “Increased distribution through eCommerce channels continues to be a strategic focus of Amara to drive both topline revenue and to maximize margins that come from a DTC environment,” noted Jessica Sturzenegger, Amara’s CEO. Eat Well now has customers in over 35 countries. With $57.9 million (Canadian) in revenue posted in 2021, the company is confident that, with the added distribution channels and partners, its portfolio will achieve approximately $100 million in revenue in 2022. This target will also be achieved by Eat Well’s plan to upgrade and expand its production facilities to meet demand increases through its portfolio company, Belle Pulses. In 2021, Belle produced approximately 90,000 metric tons of protein. With the recent spike in global demand, fueled by Russia’s invasion of Ukraine, Belle has announced plans to increase shifts at its main plant in Saskatchewan to increase Canadian annual production capacity to nearly 100,000 metric tons annually. In addition, the company will also add up to an additional 15,000 metric tons per year of annual production capacity at its United States facility (https://ibn.fm/Aurer). “Belle is receiving increased recognition from international customers looking to secure quality, safe and reliable proteins at scale,” noted Mark Coles, Eat Well’s Chief Investment Officer (“CIO”). “Shareholders should know that Belle is increasing its production capacity as it is our goal to help support the global food industry. We will continue to expand Belle’s operations and are looking forward to showing the world its ability to procure, process, and deliver proteins to the international marketplace,” he added. With the growing demand for food, given current global supply chain interruptions and the growing potential of the plant-based sector, Eat Well Investment group is optimistic that its future is bright. Through its strategic investments and partnerships with key distributors in the industry, the company is confident that it will achieve its 2022 revenue targets while also creating tremendous value for its shareholders. For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

• The majority of music industry revenue is not distributed to artists but to the labels and distribution companies that own them
• Friendable’s flagship offering, in conjunction with the recently acquired Artist Republik and FeaturedX, offers artists a 360-degree platform for music creation, distribution, and marketing – a one-of-a-kind experience
• TuneCore announced that it would be changing its pricing structure, making it more affordable for musicians looking to distribute their music on their own, but has not changed offering to include all of the Fan Pass Live solutions

In the past, artists looking to distribute their music had very few options, and these options were often linked to a relationship with a record label. In 2018, Rolling Stone published an article about how much musicians bring home from the revenue earned in the music industry – 12%. That is not 12% per musical artist, but the industry as a whole. At that time, the industry was valued at $43 billion across on-demand streaming, CD sales, radio play, live events, and advertising. Still, artists only shared a small portion of these earnings ($5 billion) (https://ibn.fm/S0TSp). One of the biggest pain points faced by independent music artists in the industry today is the high cost associated with creating, distributing, and marketing their music. In July 2020, Friendable (OTC: FDBL) released the Fan Pass Live artist platform and has since grown exponentially, increasing the number of artists and acquiring Artist Republik and FeaturedX in January 2022. Combined, Fan Pass Live now offers a 360-degree artist platform that embraces creation, distribution, and marketing – minus label control, in what can be described as an “anti-label” movement. The Fan Pass Live offering benefits both artist and fan, creating a space for live performances and exclusive content, community discussion, and more. Artists receive 100% revenue from ticket sales and tips, in addition to monthly contests and other revenue streams, with more coming soon to include NFTs and Metaverse performances. No other company currently offers a 360-degree solution for artists, like Fan Pass Live. Many only focus on production and others on distribution or marketing – not all-in-one like Fan Pass Live. Other music distribution services are feeling the pressure from Fan Pass Live’s total embodiment of the independent artist experience, changing pricing structures to be more in line with what is being offered elsewhere. For example, the biggest announcement in 16 years for music distribution service TuneCore came last week when the company announced that it would change its subscription pricing structure. “We’ve spent a year speaking directly to artists and labels about how we can make our service better for them. What emerged is: artists want to be able to test their new music for free before distributing to all services, and they want to release the music they are creating instantly, regularly, and seamlessly with one annual subscription enabling unlimited music distribution,” Andreea Gleeson, TuneCore CEO, stated (https://ibn.fm/Afiuy). “TuneCore’s new program gives self-releasing artists at any stage of their careers the freedom to choose the plan that works best for them, while maintaining the high quality of service TuneCore is known for. With TuneCore Unlimited, artists pay less and earn more.” Despite the changes in TuneCore’s subscription, artists still gain more when using Fan Pass Live’s 360-degree artist platform with options for one-time or subscription distribution services with no annual fees and 100% of royalties paid to the musician. In addition to low pricing, Fan Pass Live’s promotion offering includes social links, playlisting, PR, radio promo, distribution, ticketed live streaming, and much more – a list unmatched in the industry and unattainable by TuneCore despite changing their pricing structure. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Lexaria, a global innovator of drug delivery platforms, recently filed a pre-IND meeting request letter with the FDA, initiating communication regarding the development of its DehydraTECH-CBD as a treatment for hypertension
• The company has been undertaking preparatory programs in readiness for the meeting, as well as an IND application filing
• The pre-IND meeting will confirm the details of the company’s IND-enabling program
• Lexaria also announced it had licensed its DehydraTECH technology to AnodGen, with the announcement following similar out-licensing agreements with Valcon Medical and Premier Science

Early last September, global innovator Lexaria Bioscience (NASDAQ: LEXX) was pleased to announce it had formally commenced the process toward an Investigational New Drug (“IND”) application filing with the Food and Drug Administration (“FDA”) with its DehydraTECH(TM)-processed cannabidiol (“CBD”) for the treatment of hypertension (https://ibn.fm/WQFnA). According to the September 8 news release, Lexaria had retained the services of an expert regulatory affairs and quality assurance consulting group that would help prepare the company for a pre-IND meeting with the FDA. The group would also assist Lexaria with designing the requisite non-clinical, clinical, and related product development IND-enabling work/program meant to be finalized before the company files its IND application. Through the intervening period, Lexaria has made progress bringing it closer to achieving these goals, recently reporting it had filed a pre-IND meeting request letter with the FDA. The request, to which the federal agency had already responded and set a target date of July 30, 2022 (subject to the fulfillment of certain conditions), formally initiated communication with the FDA concerning the development of DehydraTECH-CBD as a treatment for hypertension (https://ibn.fm/PoR5K). “We are excited to take this important first regulatory step with the FDA for the development of our DehydraTECH-CBD for the treatment of hypertension,” commented Lexaria President John Docherty. “Submission of this request letter initiates formal communication with the FDA regarding our IND clinical trial plans in order to help define the critical path for clinical development and marketing approval of our potentially very significant new hypertension therapeutic.” The pre-IND meeting is intended to confirm the details and acceptability of Lexaria’s IND-enabling work, which is set to be completed after the meeting has been held. This work has been made possible by the company’s growing body of evidence showing DehydraTECH-CBD’s capacity to potentially treat hypertension. Through its successfully completed studies – HYPER-H21-1, HYPER-H21-2, and HYPER-H21-3 – Lexaria has not only demonstrated that DehydraTECH-CBD lowers the human blood pressure relative to placebo and reduces arterial stiffness but also that it does not cause any adverse effects. According to the company’s recent statement, efficacy and the lack of negative side effects are the two main goals of FDA-registered clinical studies. Following the pre-IND meeting and the completion of the IND-enabling development program, Lexaria expects to then proceed with its full IND application filing expected in late 2022 or early 2023. Meanwhile, the company also celebrated another milestone that saw it expand the list of licensees. In a recent announcement, Lexaria reported that its wholly owned subsidiary, Lexaria Pharmaceutical Corp., had awarded a five-year, non-exclusive DehydraTECH license to AnodGen Bioceuticals of Ireland (https://ibn.fm/RxIVe). The license allows AnodGen, a newly established contract manufacturing organization business, to manufacture and distribute DehydraTECH-processed cannabinoid active pharmaceutical ingredient (“API”) powders within Europe (including the UK), Australia, and New Zealand. The license also covers pharmaceutical and medical product applications for psychoactive cannabinoids and medical product applications for non-psychoactive cannabinoids. AnodGen can also manufacture and sell the API powders to third-party companies for their own products, subject to the fulfillment of specific conditions. On its part, Lexaria will receive royalty fees for all API powders sold that utilize the DehydraTECH drug delivery technology. This licensing agreement comes on the heels of two similar agreements that saw Lexaria Pharmaceutical Corp. grant a European and UK license to medical cannabis manufacturer Valcon Medical A/S (https://ibn.fm/atOS7) and a license to Premier Wellness Science Co. Ltd to deploy DehydraTECH within the Japanese non-pharmaceutical market (https://ibn.fm/ALjfa). “We are focused on larger national and international applications for DehydraTECH, primarily but not entirely in the pharmaceutical sector. These are our areas of interest that we expect will provide significant revenue streams over time…,” commented Lexaria CEO Chris Bunka in a January letter to shareholders (https://ibn.fm/cZwn3). With the series of out-licenses announced recently, Lexaria appears to be inching closer to realizing this goal. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX